Areta Kupchyk is an FDA lawyer who advises biotechnology, medical device, and pharmaceutical companies, as well as health care providers and institutions, researchers, and investors on FDA related matters. She co-chairs the firm’s Food and Drug Law practice group and is resident in the firm's Washington, D.C. office. Areta draws upon almost 10 years of experience as Associate Chief Counsel for Drugs and Biologics and Assistant General Counsel for Litigation at the FDA to provide clients with nuanced counsel on FDA’s current views for meeting pre- and post-approval requirements.